Sebastian Schwind

30PUBLICATIONS
39CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Microbial geneticsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Apr 19, 2024
Single-cell multiomic dissection of response and resistance to chimeric antigen receptor T cells against BCMA in relapsed multiple myeloma.

Michael Rade, Nora Grieb, Ronald Weiss

|Jan 06, 2024
Cellular dynamics following CAR T cell therapy are associated with response and toxicity in relapsed/refractory myeloma.

Luise Fischer, Nora Grieb, Patrick Born

|Oct 28, 2023
MicroRNA Expression Patterns Reveal a Role of the TGF-β Family Signaling in AML Chemo-Resistance.

Paula Reichelt, Stephan Bernhart, Franziska Wilke

|Feb 25, 2023
Clinical Implications of the FLT3-ITD Allelic Ratio in Acute Myeloid Leukemia in the Context of an Allogeneic Stem Cell Transplantation.

Madlen Jentzsch, Lara Bischof, Dominic Brauer

|Jan 20, 2023
Prognostic value of baseline and early response FDG-PET/CT in patients with refractory and relapsed aggressive B-cell lymphoma undergoing CAR-T cell therapy.

Thomas Walter Georgi, Lars Kurch, Georg-Nikolaus Franke

|Dec 18, 2022
Prognostic impact of the AML ELN2022 risk classification in patients undergoing allogeneic stem cell transplantation.

Madlen Jentzsch, Lara Bischof, Jule Ussmann

Pageof 5

Frequent Collaborators

23 joint publications

Madlen Jentzsch

16 joint publications

Vladan Vucinic

13 joint publications

Georg-Nikolaus Franke

12 joint publications

Uwe Platzbecker